Clinical Trial Update: A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a vitamin/nutriceutical formulation for Alzheimer's disease and mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Vitamin/Nutriceutical formulation

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED